Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 1
Submit an article Journal homepage
3,916
Views
3
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis

Yu Lua Department of General Practice, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, ChinaView further author information
,
Xiaoyan Zhanga Department of General Practice, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, ChinaView further author information
,
Jiyu Ninga Department of General Practice, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, ChinaView further author information
&
Manyan Zhangb Department of Respiration, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, ChinaCorrespondence[email protected]
View further author information
Article: 2169531 | Received 28 Jun 2022, Accepted 13 Jan 2023, Published online: 30 Jan 2023

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Keith A Betts, Sophie Gao, Saurabh Ray & Adam J Schoenfeld. (2024) Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer. Future Oncology 20:13, pages 851-862.
Read now

Articles from other publishers (2)

Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian & Dhruv Bansal. (2024) Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors. Cancers 16:6, pages 1225.
Crossref
David E. Dawe, Rebekah Rittberg, Iqra Syed, Mary Kate Shanahan, Daniel Moldaver, Oliver Bucher, Katie Galloway, Kayla Reynolds, James T. Paul, Craig Harlos, Julian O. Kim & Shantanu Banerji. (2023) Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada. Frontiers in Oncology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.